Among the parameters tested in the research, gender, therapies for ESCC before the development of fistula, the type of esophageal fistula, the treatment of esophageal fistula and the Hb level were significant factors in predicting the survival time. This evidence concerns the gene GSTM1 and esophageal squamous cell carcinoma.